News|Articles|June 1, 2016

PTSM: Pharmaceutical Technology Sourcing and Management

  • PTSM: Pharmaceutical Technology Sourcing and Management-06-07-2016
  • Volume 11
  • Issue 6

Raman Raw Material Analyzer Adds Chemometrics Capabilities

The Thermo Scientific TruScan RM Analyzer features a chemometrics package that allows users to build customized models for both qualitative and quantitative sample predictions.

The Thermo Scientific TruScan RM Analyzer for raw material identification and finished product inspection performs through sealed packaging to minimize contamination and exposure and offers other enhanced compliance features for regulated environments.

A new chemometrics package that integrates with the analyzer allows users to build customized models for both qualitative and quantitative sample predictions. Thermo Fisher designed this feature to enable faster, more informed decisions at the point of need, leading to faster process times.

The TruTools package leverages Eigenvector Research Inc.’s SOLO standalone chemometrics software. Advanced TruScan RM users can customize acquisition parameters, including number of scans, exposure time and laser power, then export the scan data in a SPC file format. This data is imported into SOLO, where users can build custom models that can then be deployed onto the TruScan RM handheld analyzer.

Source: Thermo Fisher Scientific


Related to this article

CPHI Milan 2026: Nitrosamine Risk Mitigation, Part 2
Mitigating nitrosamine risk requires assessing each product individually, says Bram Baert, Global Head of Regulatory Affairs at Capsugel, and Sandrine Picco, Senior Analytical Specialist on Capsugel's Innovaform Accelerator Team, in this interview with PharmTech.
Trophy and confetti on light background, top view with space for text. Victory concept | Image Credit: ©New Africa -stock.adobe.com
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
PharmTech Weekly Roundup—October 2, 2026
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.